Format

Send to

Choose Destination
J Clin Oncol. 2012 Aug 10;30(23):2885-90. doi: 10.1200/JCO.2011.39.4411. Epub 2012 Jul 16.

Social influences on clinical outcomes of patients with ovarian cancer.

Author information

1
Department of Psychology, University of Iowa, E11 Seashore Hall, Iowa City, IA 52242, USA. susan-lutgendorf@uiowa.edu

Abstract

PURPOSE:

Previous research has demonstrated relationships of social support with disease-related biomarkers in patients with ovarian cancer. However, the clinical relevance of these findings to patient outcomes has not been established. This prospective study examined how social support relates to long-term survival among consecutive patients with ovarian cancer. We focused on two types of social support: social attachment, a type of emotional social support reflecting connections with others, and instrumental social support reflecting the availability of tangible assistance.

PATIENTS AND METHODS:

Patients were prospectively recruited during a presurgical clinic visit and completed surveys before surgery. One hundred sixty-eight patients with histologically confirmed epithelial ovarian cancer were observed from the date of surgery until death or December 2010. Clinical information was obtained from medical records.

RESULTS:

In a Cox regression model, adjusting for disease stage, grade, histology, residual disease, and age, greater social attachment was associated with a lower likelihood of death (hazard ratio [HR], 0.87; 95% CI, 0.77 to 0.98; P = .018). The median survival time for patients with low social attachment categorized on a median split of 15 was 3.35 years (95% CI, 2.56 to 4.15 years). In contrast, by study completion, 59% of patients with high social attachment were still alive after 4.70 years. No significant association was found between instrumental social support and survival, even after adjustment for covariates.

CONCLUSION:

Social attachment is associated with a survival advantage for patients with ovarian cancer. Clinical implications include the importance of screening for deficits in the social environment and consideration of support activities during adjuvant treatment.

PMID:
22802321
PMCID:
PMC3410403
DOI:
10.1200/JCO.2011.39.4411
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center